Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Clinical trial NCT00258856 · COMPLETED

Trial details

NCT number: NCT00258856
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis Meningococcal Infection

Start date: 2006-01-01
Primary completion: 2007-03-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.